Skip to NavigationSkip to content

Purespring Therapeutics to appoint Richard Francis as CEO

Published on: 11/01/21

Purespring Therapeutics, a kidney-focused AAV gene therapy company, has announced it will appoint Richard Francis as Chief Executive Officer from February this year.

Francis is a pharmaceutical executive with over 25 years’ experience in building sustainable, world-class life science companies. He most recently held the role of Chief Executive Officer of Sandoz, a division of Novartis, and was also a member of the Novartis Executive Committee. Richard joined Novartis from Biogen Idec, where he held global and country leadership positions during his 13-year career with the company. He has also worked at Sanofi-Synthelabo and Wyeth, where he held various commercial roles.

In addition to his full-time role as Chief Executive of Purespring, Richard will spend part of his time as a Partner at Syncona Investment Management Limited, providing valuable advice and commercial and operational expertise across the Syncona portfolio.

Francis himself said: “I am delighted to be joining Purespring at the beginning of this exciting journey and to be building a world class gene therapy company. I was attracted to Purespring because of the strength of the science and the world-class founding team who are leading experts in the kidney and gene therapy fields.

“Purespring will be an agile, dynamic company that focuses on building a talented team that truly wants to make a difference to the millions of people suffering from kidney related diseases.”

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches